Abstract-Biosensors based on the spectral correlation interferometry (SCI) with assistance of magnetic nanoparticles (MP) have been developed for medical diagnostics. The SCI has been adapted for studies of affinity constants of MP covered by antibodies and for detection of protein molecules in human serum. The 50-nm MP employed as labels yield toO-fold amplification of the SCI signals to meet the requirements for myocardial infarction diagnostics.
INTRODUCTION
Spectral correlation interferometry allows recording of changes of thickness LJd of the interacting biomolecules on the sensor chip with picometer scale resolution averaged over the sensor channels [1] . SCI method uses standard cover glass slips as affordable single-used sensor chips ( Fig. 1 ) 
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II. MATERIALS AND METHODS
The MP are very attractive nanolabels for biosensors [2] . Such application required knowledge of recognition properties of antibodies (AB) immobilized on MP surface. The affmity constants of AB coupled with MP by various methods were calculated using association model [3] adapted to the SCI. The values of the constants of association ka and dissociation kd as well as of the maximal signal Rma x were chosen to provide best fitting of the observed sensogram sections during passing the analyte at concentration C to the approximating function:
The examples of sensograms for detection of protein marker of myocardial infarction -cardiac troponin I (cTnl) are shown in Fig. 2 . The sensorgams demonstrate all stages of the sandwich immunoassays with using of MP as labels as well as epoxylated and biotinylated chip surfaces. Values of kinetic association constants observed at the MP stage are 2-3 orders of magnitude higher than molecular AB association with AG. Such good kinetic characteristics of MP binding are explained by polyvalence ofMP having several AB simultaneously. The 50-nm MP employed as labels yield 100-fold amplification of the SCI signals. The achieved detection limit of cTnl is 0.1 ng/ml meet the requirements for myocardial infarction diagnostics. The SCI biosensors functionality has been demonstrated for diagnostics of autoimmune diseases, e.g. for registration of autoantibodies against thyroglobulin and thyroperoxidase in human serum. Clinically relevant limits of autoantibodies detection are achieved at label free mode. The high sensitivity and wide dynamic range make the SCI biosensors with affordable single-used glass slips as the sensor chips the attractive instruments for medical diagnostics.
